treatment of uveitis with immunosuppressive agents
Clicks: 127
ID: 202557
1993
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
127 views
11 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #282 of 456 articles by views in Bioinformatics
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 456 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The spectrum of uveitis constitutes one of the major causes of blindness. Advances in our understanding of the underlying mechanisms have altered the diagnostic and therapeutic approaches. The most notable development is the increasing usage of several immunosuppressive agents. A systematic approach in making accurate diagnosis is central to employment of specific, more effective treatment. One should be cognizant of the potential benefits and risks of each of these agents before exposing the patients to these very potent drugs.
| Reference Key |
narsing1993indiantreatment
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Rao Narsing;Buddi Rajeev |
| Journal | Bioinformatics |
| Year | 1993 |
| DOI |
DOI not found
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.